John Park
Impact in
- Genetics top 0.5%
- Glioma Diagnosis and Treatment
- Internal Medicine top 1%
- Venous Thromboembolism Diagnosis and Management
Papers in
- Oncology 63
- Colorectal Cancer Surgical Treatments 23
- Cancer Immunotherapy and Biomarkers 14
-
- Melanoma and MAPK Pathways 7
- Co-authors
- Slawomir J. Marecik (45 shared papers)Leela M. Prasad (33 shared papers)Howard A. Fine (2 shared papers)Paul Duic (1 shared paper)Lyndon Kim (1 shared paper)Teri Kreisl (1 shared paper)Megan Mackey (1 shared paper)John A. Butman (1 shared paper)
- Journals
- Journal of Clinical Oncology (18 papers)Diseases of the Colon & Rectum (11 papers)Cancer Research (9 papers)The American Surgeon (9 papers)World Journal of Surgery (3 papers)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
John Park
204 papers receiving 7.3k citations
John Park's Hit Papers
Peers
Comparison fields: 5 of 204
- Genetics 1.2k
- Internal Medicine 294
- Oncology 1.7k
- Cancer Research 516
- Gastroenterology 187
Countries citing papers authored by John Park
This map shows the geographic impact of John Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Park more than expected).
Fields of papers citing papers by John Park
This network shows the impact of papers produced by John Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Park. The network helps show where John Park may publish in the future.
Co-authors
The 25 scholars most cited alongside John Park, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 226 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma Hit paper breakdown → | 2008 | 1282 |
| 2 | Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab Hit paper breakdown → | 2016 | 621 |
| 3 | A specific antidote for dabigatran: functional and structural characterization Hit paper breakdown → | 2013 | 440 |
| 4 | 2005 | 402 | |
| 5 | 2007 | 248 | |
| 6 | 1961 | 195 | |
| 7 | 2013 | 178 | |
| 8 | 2009 | 177 | |
| 9 | Connecting Informal and Formal Learning Experiences in the Age of Participatory Media | 2008 | 161 |
| 10 | 2010 | 157 | |
| 11 | 1999 | 151 | |
| 12 | Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptor. | 2000 | 147 |
| 13 | 2004 | 133 | |
| 14 | 2001 | 132 | |
| 15 | 2010 | 123 | |
| 16 | 2000 | 122 | |
| 17 | 2010 | 92 | |
| 18 | 2001 | 90 | |
| 19 | 2002 | 84 | |
| 20 | 2010 | 82 |
About John Park
John Park is a scholar working on Oncology, Molecular Biology, Surgery, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 226 papers that have together received 7.6k indexed citations. Recurring topics across this work include Colorectal Cancer Surgical Treatments (23 papers), Cancer Immunotherapy and Biomarkers (14 papers), Anorectal Disease Treatments and Outcomes (8 papers), Melanoma and MAPK Pathways (7 papers), Ocular Oncology and Treatments (7 papers), Cancer Research and Treatments (7 papers), Diverticular Disease and Complications (6 papers) and Pain Mechanisms and Treatments (6 papers). The work is most often cited by research in Genetics (1.2k citations), Internal Medicine (294 citations), Oncology (1.7k citations), Cancer Research (516 citations) and Gastroenterology (187 citations). John Park has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Slawomir J. Marecik, Leela M. Prasad, Howard A. Fine, Paul Duic, Lyndon Kim, Teri Kreisl, Megan Mackey, John A. Butman, Paul S. Albert and Nancy Garren. Their work appears in journals such as Journal of Clinical Oncology, Diseases of the Colon & Rectum, Cancer Research, The American Surgeon and World Journal of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.